SET and early-onset autosomal dominant Alzheimer disease: Given extensive involvements of SET in Alzheimer's disease, PCOS, and cancers, identification of ZFX as a potent SET regulator is a meaningful step, and further investigations into the ZFX-SET signaling network may provide useful information for the development of new therapeutic modality against human diseases.